Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: The INTERNEO individual patient data pooled analysis.
Udovicich C, Koo K, Michael Bryant J, Bugarini A, Huo M, Hwan Kim K, Derek Li Y, Oliver DE, Patel S, Rogers S, Chicoine MR, Foote MC, Kim SH, Mahadevan A, Pinkham MB, Sia J, Haghighi N; INTERNEO Investigators. Udovicich C, et al. Among authors: oliver de. Radiother Oncol. 2025 Jan;202:110641. doi: 10.1016/j.radonc.2024.110641. Epub 2024 Nov 22. Radiother Oncol. 2025. PMID: 39579871
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.
Khatri VM, Mestres-Villanueva MA, Yarlagadda S, Doniparthi A, Smith DB, Nakashima JY, Bryant JM, Zhao D, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Williams NO, Mahtani RL, Ahluwalia MS, Soliman HH, Han HS, Soyano AE, Kim Y, Kotecha R, Beyer SJ, Ahmed KA. Khatri VM, et al. Among authors: oliver de. NPJ Breast Cancer. 2024 Nov 21;10(1):100. doi: 10.1038/s41523-024-00711-w. NPJ Breast Cancer. 2024. PMID: 39572568 Free PMC article.
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
Mills MN, Uno A, Li P, Liveringhouse C, Kim Y, Oliver DE, Perez BA, Creelan BC, Yu M, Forsyth PA, Pina Y, Ahmed KA. Mills MN, et al. Among authors: oliver de. Clin Lung Cancer. 2024 Jul;25(5):417-423.e1. doi: 10.1016/j.cllc.2024.04.005. Epub 2024 Apr 10. Clin Lung Cancer. 2024. PMID: 38719648
Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.
Bryant JM, Doniparthi A, Weygand J, Cruz-Chamorro R, Oraiqat IM, Andreozzi J, Graham J, Redler G, Latifi K, Feygelman V, Rosenberg SA, Yu HM, Oliver DE. Bryant JM, et al. Among authors: oliver de. Cancers (Basel). 2023 Oct 29;15(21):5200. doi: 10.3390/cancers15215200. Cancers (Basel). 2023. PMID: 37958374 Free PMC article. Review.
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.
Dohm AE, Nakashima JY, Kalagotla H, Jiang SX, Tang JD, Bhandari M, Kim Y, Graham JA, Khushalani NI, Forsyth PA, Etame AB, Liu JK, Tran ND, Vogelbaum MA, Wuthrick EJ, Yu HM, Oliver DE, Ahmed KA. Dohm AE, et al. Among authors: oliver de. Eur J Cancer. 2023 Oct;192:113287. doi: 10.1016/j.ejca.2023.113287. Epub 2023 Aug 7. Eur J Cancer. 2023. PMID: 37657227
67 results